Lisinopril And Hydrochlorothiazide
Product Images NDC 67296-0921

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 67296-0921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lisinopril/hctz 20/12.5 (Doc20170426134238 001)

Lisinopril/hctz 20/12.5 (Doc20170426134238 001)
This is a medication called Lisinopril/Hydrochlorothiazide. The first package contains 90 tablets of 20mg/12.5mg of the medication, manufactured by Lupin Limited in India and distributed by Redpharm Drug in Minnesota. The second package contains 30 tablets of 20/12.5mg of the medication, with lot number 5033531, and an expiration date of 05/18. The package insert should be consulted for adult dosage instructions, and the medication should be stored at 20-25C (68-77F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.